Form 4 for FLO FLOWERS FOODS INC
Accepted 2025-05-27 00:00:00 ET · period of report 2025-05-22 · accession 0001127602-25-015637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-27 | 2025-05-27 | FLO | Chubb Thomas Caldecot III | Dir | P - Purchase | $16.88 | +3,000 | 45.9K | +7% | +$50.6K |
| D | 2025-05-27 | 2025-05-22 | FLO | Chubb Thomas Caldecot III | Dir | M - OptEx | $0.00 | +6,570 | 42.9K | +18% | $0 |
| D | 2025-05-27 | 2025-05-22 | FLO | Chubb Thomas Caldecot III | Dir | M - OptEx | $0.00 | -6,570 | 0 | -100% | $0 |
| D | 2025-05-27 | 2025-05-22 | FLO | Chubb Thomas Caldecot III | Dir | A - Grant | $0.00 | +9,350 | 9,350 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-27 | P | A | 3,000 | $16.88 | 45,861 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-22 | M | A | 6,570 | $0.00 | 42,861 | D | — | — | |
| 3 | Derivative | Deferred Stock | 2025-05-22 | M | D | 6,570 | $0.00 | 0 | D | $0.00 · 2025-05-22 to — | 6,570 Common Stock | (F1) Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023) (F2) In accordance with the terms of the Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price. (F3) No expiration date. |
| 4 | Derivative | Deferred Stock | 2025-05-22 | A | A | 9,350 | $0.00 | 9,350 | D | $0.00 · 2026-05-21 to — | 9,350 Common Stock | (F1) Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023) (F2) In accordance with the terms of the Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price. (F3) No expiration date. |